Founded:
2006
Headquarters:
Cambridge, MA
Description:
BIND Therapeutics is a clinical-stage nanomedicine platform company developing Accurins, a class of highly selective, targeted therapeutics.
Founders:
Omid Farokhzad, Noubar Afeyan, Robert S. Langer
Categories:
Health Care, Biotechnology
Website:
http://bindtherapeutics.com

Detailed Description

Update

They are a clinical-stage nanomedicine platform company developing Accurins™, our novel targeted and programmable therapeutics. Accurins are designed with specified physical and chemical characteristics to target specific cells or tissues and concentrate a therapeutic payload at the site of disease to enhance efficacy while minimizing adverse effects on healthy tissues. Our strategy is to leverage our medicinal nanoengineering platform to develop our own pipeline of Accurins, initially in oncology, as well as Accurins in collaboration with biopharmaceutical companies. Our lead drug candidate, BIND-014, is in Phase 2 clinical trials for non-small cell lung cancer (NSCLC) and metastatic castrate-resistant prostate cancer (mCRPC). To date in 2013, we have announced collaborations with Amgen, Pfizer and AstraZeneca to develop Accurins based on therapeutic payloads from their product pipelines.

Current Team (14)

Update

Past Team (5)

Update

Funding Rounds (5) - $121.8M

Update

Board Members and Advisors (14)

Update

Investors (5)

Update
  • 88fe952f321d068873f70c0855032575

    RUSNANO

    $6 BN russian investment fund
  • 920ef1c9e2d2a1b871893ee51107f97c

    ARCH Venture Partners

    ARCH invests primarily in companies co-founded with leading scientists and entrepreneurs,...
  • 51c8761090bfd793b4e538c328aa35ca

    NanoDimension

    Venture capital firm
  • Aktht4eq1boptqctfosv

    Polaris Partners

    Polaris Partners is a venture company investing in digital media, life sciences, and enterprise...
  • 179e6f8b3e38a786db31104370625ec8

    Flagship Ventures

    Realizing entrepreneurial innovation is the mission of Flagship Ventures. The firm operates...

Offices/Locations (1)

Update
  • Headquarters

    325 Vassar Street

    Cambridge, MA 02139

    USA

Images (1)

Update
  • Be6a4c72be71b0c5274343a920e79d84